PT3411368T - Compostos ativantes de nrf2 e seus usos - Google Patents
Compostos ativantes de nrf2 e seus usosInfo
- Publication number
- PT3411368T PT3411368T PT177049400T PT17704940T PT3411368T PT 3411368 T PT3411368 T PT 3411368T PT 177049400 T PT177049400 T PT 177049400T PT 17704940 T PT17704940 T PT 17704940T PT 3411368 T PT3411368 T PT 3411368T
- Authority
- PT
- Portugal
- Prior art keywords
- activating compounds
- nrf2 activating
- nrf2
- compounds
- activating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662290853P | 2016-02-03 | 2016-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3411368T true PT3411368T (pt) | 2020-07-01 |
Family
ID=58018295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT177049400T PT3411368T (pt) | 2016-02-03 | 2017-02-01 | Compostos ativantes de nrf2 e seus usos |
Country Status (11)
Country | Link |
---|---|
US (3) | US9845311B2 (pt) |
EP (1) | EP3411368B1 (pt) |
JP (2) | JP7202184B2 (pt) |
CN (1) | CN108699034B (pt) |
CA (1) | CA3012702A1 (pt) |
DK (1) | DK3411368T3 (pt) |
ES (1) | ES2803779T3 (pt) |
HU (1) | HUE050141T2 (pt) |
PL (1) | PL3411368T3 (pt) |
PT (1) | PT3411368T (pt) |
WO (1) | WO2017136453A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3411361T3 (da) | 2016-02-03 | 2021-02-01 | Rigel Pharmaceuticals Inc | Nrf2-aktiverende forbindelser og anvendelser deraf |
CA3096173A1 (en) * | 2018-05-16 | 2019-11-21 | Rigel Pharmaceuticals, Inc. | Prodrugs of nrf2 activating compounds and uses thereof |
WO2022143779A1 (zh) * | 2020-12-29 | 2022-07-07 | 南京明德新药研发有限公司 | 含烯基类化合物及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW424087B (en) * | 1995-04-06 | 2001-03-01 | Janssen Pharmaceutica Nv | 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives |
US8101373B2 (en) | 2007-10-12 | 2012-01-24 | Discoverx Corporation | β-galactosidase donor fragments |
CN103002742B (zh) * | 2010-03-05 | 2016-07-13 | 卡尔约药物治疗公司 | 核转运调节剂及其应用 |
US20140256767A1 (en) | 2011-10-31 | 2014-09-11 | The Broad Institute, Inc. | Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators |
WO2014145642A2 (en) * | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Nrf2 small molecule inhibitors for cancer therapy |
ES2775433T3 (es) | 2014-08-04 | 2020-07-27 | Rigel Pharmaceuticals Inc | Análogos de fumarato y sus usos en el tratamiento de una enfermedad autoinmunitaria o una enfermedad inflamatoria |
DK3411361T3 (da) | 2016-02-03 | 2021-02-01 | Rigel Pharmaceuticals Inc | Nrf2-aktiverende forbindelser og anvendelser deraf |
-
2017
- 2017-02-01 HU HUE17704940A patent/HUE050141T2/hu unknown
- 2017-02-01 JP JP2018540420A patent/JP7202184B2/ja active Active
- 2017-02-01 PT PT177049400T patent/PT3411368T/pt unknown
- 2017-02-01 EP EP17704940.0A patent/EP3411368B1/en active Active
- 2017-02-01 DK DK17704940.0T patent/DK3411368T3/da active
- 2017-02-01 PL PL17704940T patent/PL3411368T3/pl unknown
- 2017-02-01 CA CA3012702A patent/CA3012702A1/en active Pending
- 2017-02-01 WO PCT/US2017/016069 patent/WO2017136453A1/en active Application Filing
- 2017-02-01 CN CN201780011415.0A patent/CN108699034B/zh not_active Expired - Fee Related
- 2017-02-01 US US15/422,246 patent/US9845311B2/en active Active
- 2017-02-01 ES ES17704940T patent/ES2803779T3/es active Active
- 2017-11-13 US US15/811,170 patent/US10647697B2/en active Active
-
2020
- 2020-04-02 US US16/838,699 patent/US10941135B2/en active Active
-
2022
- 2022-09-08 JP JP2022142632A patent/JP2022174199A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US10647697B2 (en) | 2020-05-12 |
US10941135B2 (en) | 2021-03-09 |
PL3411368T3 (pl) | 2020-11-16 |
WO2017136453A1 (en) | 2017-08-10 |
US20170217932A1 (en) | 2017-08-03 |
US20180258070A1 (en) | 2018-09-13 |
ES2803779T3 (es) | 2021-01-29 |
DK3411368T3 (da) | 2020-07-13 |
JP7202184B2 (ja) | 2023-01-11 |
US9845311B2 (en) | 2017-12-19 |
CN108699034A (zh) | 2018-10-23 |
CN108699034B (zh) | 2020-12-11 |
CA3012702A1 (en) | 2017-08-10 |
JP2019504093A (ja) | 2019-02-14 |
US20200339538A1 (en) | 2020-10-29 |
HUE050141T2 (hu) | 2020-11-30 |
EP3411368B1 (en) | 2020-04-08 |
EP3411368A1 (en) | 2018-12-12 |
JP2022174199A (ja) | 2022-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273236A (en) | Pyrazolopyrimidine compounds and their uses | |
HK1243741A1 (zh) | 腫瘤壞死因子受體超家族(tnfrsf)結合劑 | |
HUE057087T2 (hu) | TIGIT-hez kötõdõ ágensek és alkalmazásaik | |
GB201708652D0 (en) | Novel compounds and uses | |
IL264258B (en) | Diazahetero-bicyclic substituted compounds and their use | |
GB201714745D0 (en) | New compounds and uses | |
SG11201706029VA (en) | Anti-senescence compounds and uses thereof | |
HK1246780A1 (zh) | 氮雜-吡啶酮化合物及其用途 | |
GB201714740D0 (en) | New compounds and uses | |
HK1257539A1 (zh) | 新的化合物及其用途 | |
GB201714734D0 (en) | New compounds and uses | |
ZA201705456B (en) | Benzoxaborole compounds and uses thereof | |
IL267692A (en) | Activator of nrf2 | |
GB201616439D0 (en) | Compounds and uses | |
IL264158A (en) | Antiviral compounds and their uses | |
GB201714736D0 (en) | New compounds and uses | |
IL265531A (en) | N 3 -cyclically substituted thienouraciles and use thereof | |
PT3411361T (pt) | Compostos ativadores de nrf2 e suas utilizações | |
PL3411368T3 (pl) | Związki aktywujące nrf2 i ich zastosowania | |
GB201712110D0 (en) | New compounds and uses | |
IL253459A0 (en) | Isoergoline compounds and their uses | |
GB201718875D0 (en) | Autophagy-inhibiting compounds and uses thereof | |
GB201614224D0 (en) | Compounds and uses thereof | |
IL265617B (en) | 1-phenylpropanone compounds and their use | |
GB201720092D0 (en) | New Compounds and uses |